IQVIA Bets on Agentic AI, Selects AWS as Exclusive Cloud Provider
Event summary
- IQVIA has named Amazon Web Services (AWS) as its preferred 'agentic' cloud provider.
- The collaboration will see IQVIA deploy its AI platform on AWS to automate clinical trials, medical affairs, and healthcare analytics.
- IQVIA states that 90% of the world’s largest pharmaceutical companies already utilize both IQVIA and AWS for digital transformation.
- The partnership was announced at the AWS re:Invent conference on December 2, 2025.
The big picture
IQVIA’s decision to exclusively leverage AWS for its AI platform signals a deepening commitment to agentic AI and cloud-based solutions within the life sciences industry. This move positions IQVIA to capitalize on the growing demand for AI-driven automation in clinical trials and healthcare analytics, a market estimated to reach billions in the coming years. The agreement also underscores AWS’s continued dominance in providing cloud infrastructure to the healthcare sector, solidifying its position as a key enabler of digital transformation.
What we're watching
- Integration Risk
- The success of this partnership hinges on the seamless integration of IQVIA’s AI platform with AWS’s cloud infrastructure; any significant delays or technical challenges could impact timelines and costs.
- Competitive Response
- Other cloud providers will likely scrutinize this exclusive agreement and may attempt to poach IQVIA’s business or partner with competing clinical research organizations.
- AI Governance
- Increased reliance on agentic AI will necessitate robust governance frameworks to ensure responsible use, data privacy, and regulatory compliance within the life sciences sector.
Related topics